CELL AND GENE THERAPY INSIGHTS

October 2018 Issue

Volume 4 Issue 10

Cell and Gene Therapy Insights Volume 4 Issue 10
Download PDF

Featuring

Issue Spotlight: Update on the Latest Developments in Viral and Non-Viral Vector Manufacturing
Other articles
Webinars

SPOTLIGHT

Update on the Latest Developments in Viral and Non-Viral Vector Manufacturing
Jan Thirkettle
Guest Editor:
Jan Thirkettle, Chief Executive Officer at Transine Therapeutics

Foreword

The latest developments in viral and non-viral vector manufacturing

The latest developments in viral and non-viral vector manufacturing

Jan Thirkettle
10 December 2018
Read

Editorial

Update on the Sleeping Beauty transposon system for therapeutic applications

Update on the Sleeping Beauty transposon system for therapeutic applications

Suneel A Narayanavari
6 December 2018
Read
Lentiviral vectors in hematopoietic stem cell therapies: mainstay technology, or simply a bridge to gene editing?

Lentiviral vectors in hematopoietic stem cell therapies: mainstay technology, or simply a bridge to gene editing?

Marc Moore, John R Counsell
30 November 2018
Read

Expert Insight

Challenges and progress in lentiviral vector bioprocessing

Challenges and progress in lentiviral vector bioprocessing

Eugenio Macchiarulo, Phil Bassett, Mark Dudley
30 November 2018
Read

Innovator Insight

Standardizing viral vector manufacture: maximizing production with the TRiP SystemTM

Standardizing viral vector manufacture: maximizing production with the TRiP SystemTM

Dan Farley
2 January 2019
Read

Interview

Transmission Electron Microscopy: a Critical Component of the Vector Analytical Toolkit

Transmission Electron Microscopy: a Critical Component of the Vector Analytical Toolkit

Vanessa Carvalho
17 December 2018
Read
Joined-up thinking: success criteria for tomorrow’s viral vector production platforms

Joined-up thinking: success criteria for tomorrow’s viral vector production platforms

Phil Vanek
3 December 2018
Read
Keeping viral vector manufacturing in-house: strategic considerations for gene therapy biotechs

Keeping viral vector manufacturing in-house: strategic considerations for gene therapy biotechs

Timothy J Miller
30 November 2018
Read
Applying learnings from the bioprocess development of Luxturna™

Applying learnings from the bioprocess development of Luxturna™

J. Fraser Wright
30 November 2018
Read
Scaling up gene therapy manufacturing for multinational pivotal trials & commercialization

Scaling up gene therapy manufacturing for multinational pivotal trials & commercialization

Krzysztof Regulski
30 November 2018
Read
AAV meets exosomes: at the cutting edge of cardiovascular gene therapy

AAV meets exosomes: at the cutting edge of cardiovascular gene therapy

Roger Hajjar
30 November 2018
Read
Capacity or capability? Getting your priorities right in viral vector manufacturing

Capacity or capability? Getting your priorities right in viral vector manufacturing

Jan Thirkettle
30 November 2018
Read

Podcast

Joined-up thinking: success criteria for tomorrow’s viral vector production platforms

Joined-up thinking: success criteria for tomorrow’s viral vector production platforms

Phil Vanek
17 December 2018
Listen
Transmission Electron Microscopy: a Critical Component of the Vector Analytical Toolkit

Transmission Electron Microscopy: a Critical Component of the Vector Analytical Toolkit

Vanessa Carvahlo
3 December 2018
Listen

Conference Insight

The Growing Promise of Gene Therapy Approaches

The Growing Promise of Gene Therapy Approaches

J C Grieger, R Snyder, J Samulski et al.
10 December 2018
Read

Journal articles

Expert Insight

Logistics by design: a framework for advanced therapy developers to create optimal Logistics Platforms

Logistics by design: a framework for advanced therapy developers to create optimal Logistics Platforms

S Ellison, R McCoy, M Bell et al.
2 January 2019
Read

Webinars